Distribution of domperidone into the rat brain is increased by brain ischaemia or treatment with the P-glycoprotein inhibitor verapamil
- 1 May 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 54 (5) , 729-733
Abstract
Domperidone (DOM), a peripheral dopamine D2 receptor antagonist, is a substrate of P-glycoprotein (P-gp). Therefore, the transport of DOM into the brain may be restricted by P-gp function at the blood-brain barrier, and when the function of P-gp is impaired by ATP depletion under conditions of brain ischaemia (e.g. cerebral thrombosis), side-effects may be induced as a result of increased distribution of DOM into the brain. In this study, we investigated the effects of brain ischaemia and verapamil, a P-gp inhibitor, on the permeability coefficient-surface area product (PS values) of DOM across the blood-brain barrier by using an in-situ rat brain perfusion technique. The PS values of DOM were increased 3.4- and 3.6-fold after brain ischaemia for 10 and 20 min, respectively. Furthermore, co-administration of verapamil significantly increased the PS values of DOM by 42.6- and 43.3-fold in the normal and ischaemia groups, respectively. Brain vascular volume was not affected by ischaemia or verapamil. These results show that the transport of DOM into the brain is restricted by P-gp and that the brain distribution of DOM can be increased by cerebral ischaemia or co-administration of a P-gp inhibitor.Keywords
This publication has 11 references indexed in Scilit:
- Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal MicroscopyMolecular Pharmacology, 2000
- Increased drug delivery to the brain by P-glycoprotein inhibitionClinical Pharmacology & Therapeutics, 2000
- Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial CellsJournal of Neurochemistry, 1998
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996
- In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrierBiochemical Pharmacology, 1994
- Comparisons between thein VitroBinding of Two Substituted Benzamides and Two Butyrophenones to Dopamine‐D2Receptors in the Rat StriatumActa Pharmacologica et Toxicologica, 1986
- Regional Energy Balance in Rat Brain After Transient Forebrain IschemiaJournal of Neurochemistry, 1983
- Selective DA2 versus DA1 antagonist activity of domperidone in the peripheryEuropean Journal of Pharmacology, 1983
- On the pharmacokinetics of domperidone in animals and man I. Plasma levels of domperidone in rats and dogs. Age related absorption and passage through the blood brain barrier in ratsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981
- A new model of bilateral hemispheric ischemia in the unanesthetized rat.Stroke, 1979